These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 1999307)

  • 21. Tobacco-specific N-nitrosamines and Areca-derived N-nitrosamines: chemistry, biochemistry, carcinogenicity, and relevance to humans.
    Hoffmann D; Brunnemann KD; Prokopczyk B; Djordjevic MV
    J Toxicol Environ Health; 1994 Jan; 41(1):1-52. PubMed ID: 8277523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carcinogenic tobacco-specific nitrosamines are present at unusually high levels in the saliva of oral snuff users in Sudan.
    Idris AM; Nair J; Friesen M; Ohshima H; Brouet I; Faustman EM; Bartsch H
    Carcinogenesis; 1992 Jun; 13(6):1001-5. PubMed ID: 1600602
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Toombak: a major risk factor for cancer of the oral cavity in Sudan.
    Idris AM; Prokopczyk B; Hoffmann D
    Prev Med; 1994 Nov; 23(6):832-9. PubMed ID: 7855117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The occurrence of N-nitrosocompounds [corrected] in zarda tobacco.
    Tricker AR; Preussmann R
    Cancer Lett; 1988; 42(1-2):113-8. PubMed ID: 3242503
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carcinogenic nitrosamines in oral snuff.
    Hoffmann D; Brunnemann KD; Venitt S
    Lancet; 1988 May; 1(8596):1232. PubMed ID: 2897047
    [No Abstract]   [Full Text] [Related]  

  • 26. Tobacco-specific nitrosamines in the saliva of Inuit snuff dippers in the Northwest Territories of Canada.
    Brunnemann KD; Hornby AP; Stich HF
    Cancer Lett; 1987 Oct; 37(1):7-16. PubMed ID: 3664451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemical composition of smokeless tobacco: a survey of products sold in the United States in 2006 and 2007.
    Borgerding MF; Bodnar JA; Curtin GM; Swauger JE
    Regul Toxicol Pharmacol; 2012 Dec; 64(3):367-87. PubMed ID: 23000415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Volatile N-nitrosamines in snuff and chewing tobacco on the Swedish market.
    Osterdahl BG; Slorach SA
    Food Chem Toxicol; 1983 Dec; 21(6):759-62. PubMed ID: 6686581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of and exposure to N-nitroso compounds in tobacco.
    Tricker AR; Preussmann R
    IARC Sci Publ; 1991; (105):493-5. PubMed ID: 1855904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased levels of tobacco-specific N-nitrosamines in moist snuff on the Swedish market.
    Osterdahl BG; Jansson C; Paccou A
    J Agric Food Chem; 2004 Aug; 52(16):5085-8. PubMed ID: 15291479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tobacco-specific nitrosamines in new tobacco products.
    Stepanov I; Jensen J; Hatsukami D; Hecht SS
    Nicotine Tob Res; 2006 Apr; 8(2):309-13. PubMed ID: 16766423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemical characterization of domestic oral tobacco products: total nicotine, pH, unprotonated nicotine and tobacco-specific N-nitrosamines.
    Lawler TS; Stanfill SB; Zhang L; Ashley DL; Watson CH
    Food Chem Toxicol; 2013 Jul; 57():380-6. PubMed ID: 23517910
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Endogenous formation of nitrosamines and oxidative DNA-damaging agents in tobacco users.
    Nair J; Ohshima H; Nair UJ; Bartsch H
    Crit Rev Toxicol; 1996; 26(2):149-61. PubMed ID: 8688158
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemical profile of two types of oral snuff tobacco.
    Brunnemann KD; Qi J; Hoffmann D
    Food Chem Toxicol; 2002 Nov; 40(11):1699-703. PubMed ID: 12176096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Supercritical fluid extraction in the determination of tobacco-specific N-nitrosamines in smokeless tobacco.
    Prokopczyk B; Hoffmann D; Cox JE; Djordjevic MV; Brunnemann KD
    Chem Res Toxicol; 1992; 5(3):336-40. PubMed ID: 1504255
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of oral cavity tumors in F344 rats by tobacco-specific nitrosamines and snuff.
    Hecht SS; Rivenson A; Braley J; DiBello J; Adams JD; Hoffmann D
    Cancer Res; 1986 Aug; 46(8):4162-6. PubMed ID: 3731083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of herpes simplex virus replication and protein synthesis by non-smoked tobacco, tobacco alkaloids and nitrosamines.
    Larsson PA; Hirsch JM; Gronowitz JS; Vahlne A
    Arch Oral Biol; 1992 Nov; 37(11):969-78. PubMed ID: 1334651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Swedish snus and the Sudanese toombak: are they different?
    Idris AM; Ibrahim SO; Vasstrand EN; Johannessen AC; Lillehaug JR; Magnusson B; Wallström M; Hirsch JM; Nilsen R
    Oral Oncol; 1998 Nov; 34(6):558-66. PubMed ID: 9930371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smokeless tobacco and oral cancer: a review of the risks and determinants.
    Rodu B; Jansson C
    Crit Rev Oral Biol Med; 2004 Sep; 15(5):252-63. PubMed ID: 15470264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.